Portfolio company
Gallant Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gallant
The company develops ready-to-use mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
LEAH Labs
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
DeepScan Diagnostics
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
adivo
This biotechnology company develops species-specific therapeutic monoclonal antibodies for companion animals, primarily targeting cancer and inflammatory diseases in dogs and cats.
Okapi Sciences
The company develops antiviral drugs for veterinary applications to treat viral infections in pets and livestock.
Aratana
This company develops and commercialises biopharmaceutical medicines for dogs and cats to treat conditions including pain and inappetence for the veterinary market.
